Primaquine radical cure of Plasmodium vivax: a critical review of the literature.
BACKGROUND: Primaquine has been the only widely available hypnozoitocidal anti-malarial drug for half a century. Despite this its clinical efficacy is poorly characterized resulting in a lack of consensus over the optimal regimen for the radical cure of Plasmodium vivax. METHODS: Published studies s...
Main Authors: | John, G, Douglas, N, von Seidlein, L, Nosten, F, Baird, J, White, N, Price, R |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
BioMed Central
2012
|
Registos relacionados
-
Expanding the use of primaquine for the radical cure of Plasmodium vivax
Por: Price, RN, et al.
Publicado em: (2018) -
Weekly primaquine for radical cure of patients with Plasmodium vivax malaria and glucose-6-phosphate dehydrogenase deficiency
Por: Taylor, WRJ, et al.
Publicado em: (2023) -
Addressing health equity for breastfeeding women: primaquine for Plasmodium vivax radical cure
Por: Abla, N, et al.
Publicado em: (2024) -
Improving the radical cure of Plasmodium vivax malaria.
Por: Price, R
Publicado em: (2014) -
A comparison of two short-course primaquine regimens for the treatment and radical cure of Plasmodium vivax malaria in Thailand.
Por: Pukrittayakamee, S, et al.
Publicado em: (2010)